The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Analysts' ratings for RxSight (NASDAQ:RXST) over the last quarter vary from bullish to bearish, as provided by 3 analysts. The table below provides a concise overview of recent ratings by analysts, ...

RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in a fireside chat on Tuesday, May 26, 2026, at ...

Within the last quarter, RxSight (NASDAQ:RXST) has observed the following analyst ratings: These 4 analysts have an average price target of $31.0 versus the current price of RxSight at $28.84, ...

RxSight sees Q1 revenue up 28% YoY to $37.9M, but misses consensus of $40.14M. FY25 outlook lowered with revenue forecast cut to $160M-$175M, below consensus of $188.9M. Ready to turn the market’s ...

Needham analyst David Saxon reiterated a Buy rating on RxSight, Inc. (NASDAQ:RXST), raising the price target to $34 from $27. The analyst applauds RxSight's improved trading liquidity, track record of ...

ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

Ophthalmic device firm RxSight Inc. (Nasdaq: RXST), which went public last year, is adding to its OC footprint after inking a new office lease near its Aliso Viejo headquarters. Regulatory filings ...

On November 29, 2024, RxSight, Inc. filed a notice of data breach with the Attorney General of Montana after discovering that an unauthorized party accessed an employee’s email account. In this notice ...